Mumbai: Beacon Group has announced the appointment of Dr. Rajesh Patel as its Group CEO, effective April 1, 2026.
Dr. Rajesh Patel brings with him 36 years of extensive industry experience and a strong track record of leadership in the healthcare sector. Over the course of his distinguished career, he has built deep expertise in sales, marketing, business development, strategic growth, and operational excellence, with significant contributions across the healthcare and diagnostics industry.
As Group CEO, Dr. Rajesh Patel will lead the business operations of all three companies of Beacon Group – Beacon Diagnostics, Vector Biotek, and Biogeny Diagnostics – in alignment with the Group’s strategic vision and in close coordination with their respective CEOs. He will be responsible for driving the Group’s strategic direction, strengthening cross-company synergies, accelerating market expansion, and enhancing organizational capability across the businesses.
Beacon Group is strongly poised to emerge as a leading force in the IVD segment over the next five years. The Group has ambitious plans to address the underserved needs of Chain Labs, Key Accounts, and standalone laboratories, while continuing to strengthen its commitment to quality, innovation, service excellence, and customer-centric growth.
Dr. D. K. Joshi, Chairman of Beacon Group, is among the few seasoned and highly respected industry promoters in the sector. The Group considers the induction of Dr. Rajesh Patel as a well-considered strategic move, aligned with its long-term vision for growth, market leadership, and organizational strengthening. Beacon Group believes that Dr. Patel’s rich experience, leadership vision, and execution oriented approach will further reinforce the Group’s position in the healthcare and diagnostics sector.
Commenting on the appointment, Dr. D. K. Joshi, Chairman, Beacon Group, shared, “We warmly welcome Dr. Rajesh Patel to the Beacon family. His leadership, industry insight, and vast experience will play a pivotal role in driving our next phase of growth and excellence. His joining is a thoughtful and strategic step in line with the Group’s long term vision.”
